muscimol has been researched along with oxidopamine in 26 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 10 (38.46) | 18.7374 |
| 1990's | 8 (30.77) | 18.2507 |
| 2000's | 2 (7.69) | 29.6817 |
| 2010's | 5 (19.23) | 24.3611 |
| 2020's | 1 (3.85) | 2.80 |
| Authors | Studies |
|---|---|
| James, TA; Straughan, DW | 1 |
| Churchill, L; Dilts, RP; Kalivas, PW | 1 |
| Elliott, PJ; Lorens, SA; Mitsushio, H; Paris, JM | 1 |
| Depaulis, A; Kempf, E; Liu, Z; Marescaux, C; Vergnes, M | 1 |
| Akema, T; Chiba, A; Kimura, F | 1 |
| Kuga, T; Moroi, K; Takashi, K | 1 |
| Pan, HS; Penney, JB; Young, AB | 1 |
| Herrera-Marschitz, M; Ungerstedt, U | 1 |
| Baumeister, A; Breese, GR; Frye, G; Hulebak, KL; Mueller, RA; Napier, TC | 1 |
| Håkanson, R; Kannisto, P; Owman, C; Schmidt, G; Wahlestedt, C | 1 |
| Koob, GF; Swerdlow, NR | 1 |
| Starr, MS; Summerhayes, M | 1 |
| Fung, YK; Schwarz, RD | 1 |
| Chavez, L; DeAnda, R; Garcia-Munoz, M; Zainos, A | 1 |
| Kase, H; Koga, K; Kurokawa, M; Kuwana, Y; Nakamura, J | 1 |
| Basso, MA; Evinger, C; Powers, AS | 1 |
| Churchill, L; Kalivas, PW; Klitenick, MA | 1 |
| Choi, IG; Huh, SO; Ihn, BM; Jung, JS; Kim, YH; Song, DK; Suh, HW | 1 |
| Araki, T; Fujihara, K; Imai, Y; Itoyama, Y; Kato, H; Matsubara, M | 1 |
| Chesselet, MF; Mehta, A; Menalled, L | 1 |
| Huston, JP; Petri, D; Pum, M; Schnitzler, A; Vesper, J | 1 |
| Czarnecka, A; Kamińska, K; Konieczny, J; Lenda, T; Nowak, P | 1 |
| Abdallah, K; Artola, A; Dallel, R; Luccarini, P; Monconduit, L | 1 |
| Chen, L; Du, CX; Liu, J; Lv, SX; Sun, YN; Wang, T; Wang, Y; Zhang, J; Zhang, L; Zhang, QJ | 1 |
| Botelho, MT; Lima, JC; Moreira, TS; Oliveira, LM; Takakura, AC | 1 |
| Hanamoto, H; Kudo, C; Maegawa, H; Niwa, H; Usami, N | 1 |
1 review(s) available for muscimol and oxidopamine
| Article | Year |
|---|---|
Inhibitory mechanisms in the substantia nigra and the dopamine pathway.
Topics: Amino Acids; Amino Acids, Cyclic; Animals; Brain Mapping; Cats; Corpus Striatum; Cyclohexanecarboxylic Acids; Dopamine; Electrophysiology; Ethanolamines; gamma-Aminobutyric Acid; Glutamate Decarboxylase; Homovanillic Acid; Hydroxydopamines; Mice; Motor Activity; Muscimol; Neural Inhibition; Neural Pathways; Oxidopamine; Picrotoxin; Rats; Substantia Nigra | 1979 |
1 trial(s) available for muscimol and oxidopamine
| Article | Year |
|---|---|
GABAAergic inhibition or dopamine denervation of the A11 hypothalamic nucleus induces trigeminal analgesia.
Topics: Animals; Calcitonin Gene-Related Peptide; Denervation; Dopamine; Dorsomedial Hypothalamic Nucleus; Functional Laterality; GABA-A Receptor Agonists; gamma-Aminobutyric Acid; Male; Motor Activity; Muscimol; Neural Pathways; Neurons; Oxidopamine; Pain Measurement; Rats; Sympatholytics; Trigeminal Neuralgia | 2015 |
24 other study(ies) available for muscimol and oxidopamine
| Article | Year |
|---|---|
Autoradiographic localization of gamma-aminobutyric acidA receptors within the ventral tegmental area.
Topics: Animals; Autoradiography; Male; Muscimol; Neurons; Nucleus Accumbens; Oxidopamine; Quinolinic Acid; Quinolinic Acids; Rats; Rats, Inbred Strains; Receptors, GABA-A; Tegmentum Mesencephali; Tissue Distribution | 1992 |
Neuronal sites mediating locomotor hyperactivity following central neurokinin agonist administration.
Topics: Animals; Brain; Catheterization; Cerebral Ventricles; Chromatography, High Pressure Liquid; Haloperidol; Hydroxydopamines; Infusions, Parenteral; Male; Motor Activity; Muscimol; Neurons; Oxidopamine; Peptide Fragments; Pyrrolidonecarboxylic Acid; Rats; Rats, Inbred Strains; Substance P; Tegmentum Mesencephali | 1990 |
Involvement of the nigral output pathways in the inhibitory control of the substantia nigra over generalized non-convulsive seizures in the rat.
Topics: Animals; Brain; Dopamine; Electroencephalography; GABA Antagonists; gamma-Aminobutyric Acid; Hydroxydopamines; Male; Muscimol; Norepinephrine; Oxidopamine; Picrotoxin; Rats; Rats, Inbred Strains; Seizures; Serotonin; Substantia Nigra | 1990 |
On the relationship between noradrenergic stimulatory and GABAergic inhibitory systems in the control of luteinizing hormone secretion in female rats.
Topics: Animals; Bicuculline; Estradiol; Female; gamma-Aminobutyric Acid; Hydroxydopamines; Luteinizing Hormone; Muscimol; Norepinephrine; Ovariectomy; Oxidopamine; Periodicity; Phenoxybenzamine; Rats; Rats, Inbred Strains; Receptors, Adrenergic, alpha; Receptors, GABA-A | 1990 |
Involvement of GABAergic systems and benzodiazepine receptors in the jumping behavior induced by harmine and apomorphine in rats.
Topics: Alkaloids; Animals; Apomorphine; Brain; Diazepam; Flumazenil; Harmine; Hydroxydopamines; Male; Motor Activity; Muscimol; Oxidopamine; Pyridines; Rats; Rats, Inbred Strains; Receptors, GABA-A | 1988 |
Gamma-aminobutyric acid and benzodiazepine receptor changes induced by unilateral 6-hydroxydopamine lesions of the medial forebrain bundle.
Topics: Animals; Autoradiography; Benzodiazepines; Brain; Dopamine; Enkephalin, Leucine; Enkephalin, Leucine-2-Alanine; Flunitrazepam; Hydroxydopamines; Kinetics; Muscimol; Naloxone; Oxidopamine; Rats; Rats, Inbred Strains; Receptors, GABA-A; Spiperone; Tritium | 1985 |
The dopamine-gamma aminobutyric acid interaction in the striatum of the rat is differently regulated by dopamine D-1 and D-2 types of receptor: evidence obtained with rotational behavioural experiments.
Topics: Animals; Apomorphine; Behavior, Animal; Bicuculline; Corpus Striatum; Hydroxydopamines; Ibotenic Acid; Male; Muscimol; Nipecotic Acids; Oxidopamine; Pergolide; Picrotoxin; Rats; Rats, Inbred Strains; Receptors, Dopamine; Receptors, GABA-A; Rotation | 1987 |
Enhanced muscimol-induced behavioral responses after 6-OHDA lesions: relevance to susceptibility for self-mutilation behavior in neonatally lesioned rats.
Topics: Animals; Animals, Newborn; Biogenic Amines; Corpus Striatum; Female; Hydroxydopamines; Microinjections; Muscimol; Oxidopamine; Rats; Rats, Inbred Strains; Self Mutilation; Substantia Nigra | 1987 |
GABA suppresses stimulation-induced release of [3H]-noradrenaline from sympathetic nerve fibres in bovine ovarian follicles.
Topics: Animals; Baclofen; Bicuculline; Cattle; Desipramine; Electric Stimulation; Female; gamma-Aminobutyric Acid; Hydroxydopamines; In Vitro Techniques; Muscimol; Norepinephrine; Normetanephrine; Ovarian Follicle; Oxidopamine; Potassium Chloride; Sympathectomy, Chemical; Sympathetic Nervous System | 1987 |
The neural substrates of apomorphine-stimulated locomotor activity following denervation of the nucleus accumbens.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Apomorphine; Caudate Nucleus; Dopamine; Dose-Response Relationship, Drug; gamma-Aminobutyric Acid; Hydroxydopamines; Male; Motor Activity; Muscimol; Neurons, Efferent; Norepinephrine; Nucleus Accumbens; Oxidopamine; Rats; Rats, Inbred Strains; Receptors, GABA-A; Septal Nuclei | 1984 |
Role of the ventromedial nucleus of the thalamus in motor behaviour--II. Effects of lesions.
Topics: Animals; Apomorphine; Corpus Striatum; Dominance, Cerebral; Dopamine; Female; Humans; Hydroxydopamines; Locomotion; Male; Motor Activity; Muscimol; Oxidopamine; Posture; Rats; Rats, Inbred Strains; Receptors, Dopamine; Stereotyped Behavior; Substantia Nigra; Synaptic Transmission; Thalamic Nuclei | 1983 |
An in-vivo method for testing drugs that influence striatal dopaminergic functions.
Topics: Animals; Calcium Chloride; Corpus Striatum; Dinoprostone; Dopamine; Egtazic Acid; Humans; Hydroxydopamines; Male; Mice; Muscimol; Oxidopamine; Picrotoxin; Pilocarpine; Prostaglandins E; Scopolamine; Stereotyped Behavior | 1983 |
Turning behavior, barrel rolling, and sensory neglect induced by picrotoxin in the thalamus.
Topics: Animals; Dose-Response Relationship, Drug; Humans; Hydroxydopamines; Male; Microinjections; Motor Activity; Muscimol; Oxidopamine; Picrotoxin; Rats; Rats, Inbred Strains; Stereotyped Behavior; Thalamus | 1984 |
Adenosine A2a receptor-mediated modulation of striatal acetylcholine release in vivo.
Topics: Acetylcholine; Adenosine; Animals; Corpus Striatum; Drug Combinations; GABA Antagonists; Male; Muscimol; Oxidopamine; Parkinson Disease, Secondary; Phenethylamines; Purinergic P1 Receptor Agonists; Rats; Rats, Sprague-Dawley; Receptors, Purinergic P1; Reference Values | 1996 |
An explanation for reflex blink hyperexcitability in Parkinson's disease. I. Superior colliculus.
Topics: Animals; Blinking; Electric Stimulation; GABA Agonists; Microinjections; Muscimol; Oxidopamine; Parkinson Disease, Secondary; Rats; Rats, Sprague-Dawley; Substantia Nigra; Superior Colliculi | 1996 |
Dopamine depletion reorganizes projections from the nucleus accumbens and ventral pallidum that mediate opioid-induced motor activity.
Topics: Analgesics, Opioid; Animals; Baclofen; Dopamine; Dopamine Antagonists; Enkephalin, Ala(2)-MePhe(4)-Gly(5)-; Enkephalins; Fluphenazine; GABA Agonists; Globus Pallidus; Locomotion; Male; Microinjections; Motor Activity; Motor Neurons; Muscimol; Neural Pathways; Nucleus Accumbens; Oxidopamine; Rats; Rats, Sprague-Dawley; Sympatholytics | 1998 |
Central GABAA and GABAB receptor modulation of basal and stress-induced plasma interleukin-6 levels in mice.
Topics: Animals; Baclofen; Brain; Dizocilpine Maleate; GABA Modulators; Injections, Intraventricular; Interleukin-6; Male; Mice; Mice, Inbred ICR; Muscimol; Oxidopamine; Pyridazines; Receptors, GABA-A; Receptors, GABA-B; Stress, Physiological | 1998 |
Gamma-aminobutyric acidA and benzodiazepine receptor alterations in the rat brain after unilateral 6-hydroxydopamine lesions of the medial forebrain bundle.
Topics: Animals; Dopamine; Dopamine Uptake Inhibitors; Down-Regulation; Flunitrazepam; GABA Agonists; GABA Modulators; Male; Mazindol; Muscimol; Neostriatum; Neural Pathways; Oxidopamine; Parkinson Disease; Radioligand Assay; Rats; Rats, Wistar; Receptors, Dopamine; Receptors, GABA-A; Substantia Nigra; Sympatholytics; Tritium; Up-Regulation | 2002 |
Behavioral responses to injections of muscimol into the subthalamic nucleus: temporal changes after nigrostriatal lesions.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Analysis of Variance; Animals; Autoradiography; Behavior, Animal; Corpus Striatum; Dopamine Agonists; Dose-Response Relationship, Drug; GABA Agonists; In Situ Hybridization; Male; Muscimol; Oxidopamine; Rats; Rats, Sprague-Dawley; Substantia Nigra; Subthalamic Nucleus; Time Factors; Tritium | 2005 |
GABAA-receptor activation in the subthalamic nucleus compensates behavioral asymmetries in the hemiparkinsonian rat.
Topics: 3,4-Dihydroxyphenylacetic Acid; Adrenergic Agents; Amphetamine; Animals; Disease Models, Animal; Dizocilpine Maleate; Dopamine; Dose-Response Relationship, Drug; Functional Laterality; GABA-A Receptor Agonists; Homovanillic Acid; Male; Medial Forebrain Bundle; Mental Disorders; Muscimol; Neuroprotective Agents; Oxidopamine; Parkinson Disease; Rats; Rats, Wistar; Receptors, GABA-A; Statistics, Nonparametric; Subthalamic Nucleus; Time Factors | 2013 |
Decreased behavioral response to intranigrally administered GABAA agonist muscimol in the lactacystin model of Parkinson's disease may result from partial lesion of nigral non-dopamine neurons: comparison to the classical neurotoxin 6-OHDA.
Topics: 3,4-Dihydroxyphenylacetic Acid; Acetylcysteine; Animals; Cell Count; Corpus Striatum; Dopamine; Dose-Response Relationship, Drug; GABA-A Receptor Agonists; Homovanillic Acid; Locomotion; Male; Muscimol; Neurons; Oxidopamine; Parkinson Disease; Parkinsonian Disorders; Rats, Wistar; Receptors, GABA-A; Substantia Nigra | 2015 |
Involvement of lateral habenula α1 subunit-containing GABA
Topics: Action Potentials; Animals; Apomorphine; Depression; Dopamine Agonists; GABA Antagonists; GABA-A Receptor Agonists; Habenula; Male; Muscimol; Neural Inhibition; Neurons; Oxidopamine; Parkinsonian Disorders; Picrotoxin; Prefrontal Cortex; Rats, Sprague-Dawley; Receptors, GABA-A; Serotonin | 2017 |
The involvement of the pathway connecting the substantia nigra, the periaqueductal gray matter and the retrotrapezoid nucleus in breathing control in a rat model of Parkinson's disease.
Topics: Animals; Chemoreceptor Cells; Disease Models, Animal; GABA Agonists; Glutamate Decarboxylase; Gray Matter; Hypercapnia; Male; Muscimol; Neural Pathways; Oxidopamine; Parkinson Disease; Periaqueductal Gray; Phosphopyruvate Hydratase; Pulmonary Ventilation; Rats; Rats, Wistar; Substantia Nigra; Sympatholytics; Tyrosine 3-Monooxygenase | 2018 |
Dopaminergic Modulation of Orofacial Mechanical Hypersensitivity Induced by Infraorbital Nerve Injury.
Topics: Animals; Cranial Nerves; Dopamine; Extracellular Signal-Regulated MAP Kinases; Facial Nerve Injuries; GABA-A Receptor Agonists; gamma-Aminobutyric Acid; Hyperalgesia; Hypothalamus; Male; Muscimol; Neuralgia; Oxidopamine; Pain Measurement; Pain Threshold; Phosphorylation; Quinpirole; Rats; Rats, Wistar; Receptors, Dopamine D2; Spinal Cord | 2020 |